Chadi is joined by experts Jennifer Wargo, MD, Nazli Dizman, MD, and Sumanta (Monty) Pal, MD, from The University of Texas MD Anderson Cancer Center and City of Hope, to unravel the intricate relationship between the microbiome and cancer. Delving into the historical context and evolution of this connection in oncology, they share insights on manipulating the microbiome and its potential impact on specific cancers, discuss the role of dietary interventions in cancer research and management, and more. Together, they address skepticism surrounding the microbiome’s significance in cancer, offering evidence-based arguments that demystify misconceptions and present compelling facts about the microbiome’s crucial role in understanding and treating cancer.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
